Sanofi Ventures and Novartis Venture Fund have returned to back small molecule drug developer Expansion Therapeutics' series B round.

Addiction management services provider Wayspring boosted its overall funding to about $100m in a round featuring Centene, Caresource and existing investor Blue Venture Fund.

Deep Nishar, formerly an Americas-focused senior managing partner at SoftBank’s Investment Advisers subsidiary, has announced his plans to leave the parent firm at the end of this year.

The TigerMed-backed neural diagnostics technology developer has topped up its coffers in a round co-led by Alpha Edison and Reimagined Ventures.

Alexandria Venture Investments participated in a $30m round for the gene therapy technology developer, which will use the capital to expand its partnerships.

Comcast-backed real estate platform developer Nomad secured $20m while Hannover Re-backed insurance software provider Sureify received $15m.

Novo and Boston Scientific-backed medical device maker Minerva has filed to raise up to $100m in an IPO on the Nasdaq Global Stock Market.

The ThunderSoft and China Re-backed AI-equipped diagnostics system developer has filed to list in Hong Kong after raising approximately $274m in funding.

SBI Group topped up its investment in the digital healthcare platform developer as it looks to create one of the largest virtual hospitals in the world.

The Engine has returned once more to back a $30m round for Kytopen, having first invested in the MIT spinout in 2017.